consolidated financial statements of the Company as of 31 March 2017). Details of the calculation are summarized below. Evaluation Criteria 1. Comparison of Net Tangible Assets Net tangible assets of SGAH x
section. Distribution costs and Administrative Expenses (SG&A) In 2Q19, the Company’s distribution costs and administrative expenses was THB 238.2mn, increased by THB 47.9mn, or 25.2%% YoY from THB 190.2mn
subsidiaries as details below: (Unit: Baht millions) For the year ended 31st March Consolidated financial statement Apr 2019 - Mar 2020 Apr 2018 - Mar 2019 Change % Change Revenue from sales & service 2,756.44
value of consideration which is the basis giving the highest result of transaction. The outcome is calculated from the Company’s consolidated financial statements in interim review version for the 9-month
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
Distribution Channels Quarter 2 of 2017 Quarter 2 of 2016 Variation THB % Domestic Restaurant and Bakery Business 1,408.7 1,403.2 5.5 0.4 Food and Bakery Wholesales Business 160.0 182.1 (22.1) (12.1) Overseas
Classified by Distribution Channels Quarter 3 of 2017 Quarter 3 of 2016 Variation THB Domestic Restaurant and Bakery Business 1,615 1,652 (37) Food and Bakery Wholesales Business 231 233 (1) Overseas
, the consolidated financial statements included the business of manufacturing and distribution of dialysis and medical equipment of a subsidiary during Q1 of 2018, with the sales revenue of 84.43 million